Technology | Oncology Information Management Systems (OIMS) | July 15, 2019

RaySearch Releases Version 3A of RayCare Oncology Information System

New features include RayCare Flow to connect RayStation treatment planning system with workflow management capabilities of RayCare and RayCare PACS

RaySearch Releases Version 3A of RayCare Oncology Information System

July 15, 2019 — RaySearch has released RayCare 3A, a new version of the next-generation oncology information system (OIS). RayCare is designed to support the workflow in a modern oncology center, connecting the different oncology disciplines, boosting efficiency and ensuring optimal use of resources. RayCare is being continually developed in collaboration with some of the leading cancer centers worldwide, according to RaySearch.

RayCare is now in clinical use at three centers worldwide. The most recent addition is Heidelberg University Hospital in Germany, who started using RayCare clinically in May 2019. The other two centers have been using RayCare since 2018, first at Iridium Cancer Network in Belgium, and at Provision Cares Proton Therapy Center in Nashville. RaySearch said the release of RayCare 3A is the first of this year`s two major versions.

RayCare 3A brings several new features to support the efficiency and workload control for radiation therapy users. The enhanced ‘Home’ workspace provides a comprehensive overview for each user’s activities, including new features such as task statistics to guide daily priorities and the option to pin tasks of interest. The RayCare workflow engine now supports modular patient workflows. This advanced feature enables the evolution of the patient workflow by adding modules of tasks when different clinical decision points are reached. The modularization of the digital workflows makes it possible to tailor the workflows to the specific patient needs and further streamline the flow of the clinic.

It also adds the patient chart summary feature that provides an at-a-glance patient-centered overview and a hub for quick navigation to important workspaces. It will also be possible to automatically trigger plan generation protocols in RayStation from RayCare, based on availability of image data. Furthermore, there are usability and performance enhancements throughout the product as well as extended connectivity with other hospital systems.  

RayCare 3A introduces RayCare Flow, a feature package designed to connect the RayStation treatment planning system with the workflow management capabilities of RayCare and RayCare PACS (picture archiving and communication system). RayCare Flow optimizes the treatment planning process by providing automated task management for all the steps in the planning workflow. With this solution, RayCare becomes the environment from which treatment planning is coordinated and managed. To support resource management and workload visibility of planning tasks, RayCare Flow includes an interactive real-time planning whiteboard. RayCare Flow can improve resource management, increase efficiency of treatment planning workflow and capture all clinical communications, as well as automate image management.

For more information: www.raysearchlabs.com

Related Content

Researchers at Karolinska Institutet in Sweden and Tampere University in Finland have developed a method based on artificial intelligence (AI) for histopathological diagnosis and grading of prostate cancer

From left: Peter Ström, Martin Eklund, Kimmo Kartasalo, Henrik Olsson och Lars Egevad, researchers at Karolinska Institutet in Sweden. Photo courtesy of Stefan Zimmerman

News | Prostate Cancer | January 20, 2020
January 20, 2020 — Researchers at Karolinska Institutet in Sweden and...
Trends in Overall Cancer Mortality Rates by Sex, United States, 1930 to 2017. Rates are age adjusted to the 2000 US standard population

Trends in Overall Cancer Mortality Rates by Sex, United States, 1930 to 2017. Rates are age adjusted to the 2000 US standard population. Chart courtesy of the American Cancer Society

News | Radiation Oncology | January 13, 2020
January 13, 2020 — The cancer death rate declined
Professor Samer Ezziddin, M.D., from Saarland University/Saarland University Hospital.

Professor Samer Ezziddin, M.D., from Saarland University/Saarland University Hospital. Image courtesy of Saarland University/Thorsten Mohr

 

News | Prostate Cancer | January 13, 2020
January 13, 2020 — When a non-scientist tries to imagine a scientist, the image that often arises is one of a somewha
Lung cancer patients who are inactive prior to chemoradiation are less likely to tolerate treatment and more likely to see their cancer return
News | Lung Cancer | January 08, 2020
January 8, 2020 — Numerous ...
Six of the top 20 radiotherapy stories in 2019 involved proton therapy. This includes two video inetrviews shot during a site visit to the Northwestern Medicine Proton Center in the Chicago suburb of Warrenville, Ill.

Six of the top 20 radiotherapy stories in 2019 involved proton therapy. This includes two video inetrviews shot during a site visit to the Northwestern Medicine Proton Center in the Chicago suburb of Warrenville, Ill.

Feature | Radiation Oncology | January 03, 2020 | Dave Fornell, Editor
January 3, 2020 — Here is the top 20 pieces of radiation oncology content on the Imaging Technology News (ITN) websit
Artificial intelligence was by far the hottest topic in both radiology and radiation oncology in 2019, and AI is the subject of 8 of the top 2019 ITN videos. This image is a prostate treatment plan created autonomously by an AI algorithm from RaySearch and is the subject of the No. 2 video on the list. Deep learning in radiology and radiation oncology.

Artificial intelligence was by far the hottest topic in both radiology and radiation oncology in 2019, and AI is the subject of 8 of the top 2019 ITN videos. This image is a prostate treatment plan created autonomously by a machine learning algorithm from RaySearch and is the subject of the No. 2 video on the list. 

Feature | December 30, 2019
Here are the top 20 best performing videos posted on the Imaging Technology News website (ITN) from the past year, ba
Ferrotran (formerly Combidex), based on Ferumoxtran-10, is the only contrast agent which can detect lymph node metastases as small as 2 mm diameter

Ferrotran (formerly Combidex), based on Ferumoxtran-10, is the only contrast agent which can detect lymph node metastases as small as 2 mm diameter. Standard MRI or CT are not able to detect lymph node metastases smaller than 7 – 8 mm. Since most of the oncologic patients are dying due to metastases, a precise diagnostic is of utmost importance. The detection of small metastases, combined with the very clear and contrast rich MRI image of Ferrotran, enables an earlier and more precise treatment. Therefore, Ferrotran gives the patient a much higher chance of recovery.

News | Prostate Cancer | December 24, 2019
December 24, 2019 — SPL Medical announced today that the first patient has been successfully diagnosed with suspected